Fourth Contrast Study: contrast study for patients undergoing diagnostic coronary angiography

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN16544658

Enrollment

2000

Registered

2003-09-12

Start date

2002-08-01

Completion date

Unknown

Last updated

2016-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Angiography Surgery

Interventions

Randomised study of two commonly used contrast agents (NIOPAM and Xenetix). Reactions due to contrast reaction will be recorded in a data collection form which will form the basis for a computer datab

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Patients admitted for cardiac catheterisation. 2. Approximately 2000 subjects. 3. No selection bias to gender or age group.

Exclusion criteria

Exclusion criteria: Pregnant patients will be excluded, unless patient has life threatening condition.

Design outcomes

Primary

Measure	Time frame
Clinical outcome and adverse effects of the contrast agents.	—

Secondary

Measure	Time frame
Not provided at time of registration	—

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026